Hepatitis C Virus Mediated Changes in miRNA-449a Modulates Inflammatory Biomarker YKL40 through Components of the NOTCH Signaling Pathway

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Sarma, Nayan J ^a   Tiriveedhi, Venkataswarup ^a   Subramanian, Vijay ^a   Shenoy, Surendra ^a   Crippin, Jeffrey S ^a   Chapman, William C ^a   Mohanakumar, Thalachallour ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CCAAT ENHANCER BINDING PROTEIN ALPHA; CHITINASE; MICRORNA; MICRORNA 449A; NOTCH RECEPTOR; NOTCH1 RECEPTOR; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BINDING AFFINITY; BINDING SITE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE; GENE EXPRESSION; HEPATITIS C; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LIVER FIBROSIS; MALE; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; YKL40 GENE;

ADIPOKINES; ADULT; BASE SEQUENCE; BIOLOGICAL MARKERS; CCAAT-ENHANCER-BINDING PROTEINS; DOWN-REGULATION; FEMALE; HEPACIVIRUS; HEPATITIS C; HEPATOCYTES; HUMANS; INFLAMMATION; LECTINS; LIVER CIRRHOSIS; MALE; MICRORNAS; MIDDLE AGED; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; MUTATION; NF-KAPPA B; PROMOTER REGIONS, GENETIC; RECEPTOR, NOTCH1; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

HEPATITIS C VIRUS;

EID: 84870713267     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0050826     Document Type: Article

References (48)

1. Alter MJ, Kruszon-Moran D, Nainan OV, McQuillan GM, Gao F, et al. (1999) The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 341: 556-562.
2. Lauer GM, Walker BD, (2001) Hepatitis C virus infection. N Engl J Med 345: 41-52.
3. Seeff LB, (2002) Natural history of chronic hepatitis C. Hepatology. 36: S35-46.
4. Volck B, Price PA, Johansen JS, Sorensen O, Benfield TL, et al. (1998) YKL-40, a mammalian member of the chitinase family, is a matrix protein of specific granules in human neutrophils. Proc Assoc Am Physicians 110: 351-360.
5. Johansen JS, Christoffersen P, Moller S, Price PA, Henriksen JH, et al. (2000) Serum YKL-40 is increased in patients with hepatic fibrosis. J Hepatol 32: 911-920.
6. Lee CG, Da Silva CA, Dela Cruz CS, Ahangari F, Ma B, et al. (2011) Role of chitin and chitinase/chitinase-like proteins in inflammation, tissue remodeling, and injury. Annu Rev Physiol 73: 479-501.
7. Stevens AL, Wishnok JS, Chai DH, Grodzinsky AJ, Tannenbaum SR, (2008) A sodium dodecyl sulfate-polyacrylamide gel electrophoresis-liquid chromatography tandem mass spectrometry analysis of bovine cartilage tissue response to mechanical compression injury and the inflammatory cytokines tumor necrosis factor alpha and interleukin-1beta. Arthritis Rheum 58: 489-500.
8. Ladner KJ, Caligiuri MA, Guttridge DC, (2003) Tumor necrosis factor-regulated biphasic activation of NF-kappa B is required for cytokine-induced loss of skeletal muscle gene products. J Biol Chem 278: 2294-2303.
9. Caamano J, Hunter CA, (2002) NF-kappaB family of transcription factors: central regulators of innate and adaptive immune functions. Clin Microbiol Rev 15: 414-429.
10. Fullard N, Wilson CL, Oakley F (2012) Roles of c-Rel signalling in inflammation and disease. Int J Biochem Cell Biol.
11. Cao Q, Li P, Lu J, Dheen ST, Kaur C, et al. (2010) Nuclear factor-kappaB/p65 responds to changes in the Notch signaling pathway in murine BV-2 cells and in amoeboid microglia in postnatal rats treated with the gamma-secretase complex blocker DAPT. J Neurosci Res 88: 2701-2714.
12. Cheng P, Zlobin A, Volgina V, Gottipati S, Osborne B, et al. (2001) Notch-1 regulates NF-kappaB activity in hemopoietic progenitor cells. J Immunol 167: 4458-4467.
13. Shin HM, Minter LM, Cho OH, Gottipati S, Fauq AH, et al. (2006) Notch1 augments NF-kappaB activity by facilitating its nuclear retention. EMBO J 25: 129-138.
14. Hacker H, Karin M, (2006) Regulation and function of IKK and IKK-related kinases. Sci STKE 2006: re13.
15. Johnson PF, (2005) Molecular stop signs: regulation of cell-cycle arrest by C/EBP transcription factors. J Cell Sci 118: 2545-2555.
16. Zeng C, Wang R, Li D, Lin XJ, Wei QK, et al. (2010) A novel GSK-3 beta-C/EBP alpha-miR-122-insulin-like growth factor 1 receptor regulatory circuitry in human hepatocellular carcinoma. Hepatology 52: 1702-1712.
17. Lu GD, Leung CH, Yan B, Tan CM, Low SY, et al. (2010) C/EBPalpha is up-regulated in a subset of hepatocellular carcinomas and plays a role in cell growth and proliferation. Gastroenterology 139: 632-643, 643 e631-634.
18. McManus MT, (2003) MicroRNAs and cancer. Semin Cancer Biol 13: 253-258.
19. Gracias DT, Katsikis PD, (2011) MicroRNAs: key components of immune regulation. Adv Exp Med Biol 780: 15-26.
20. Miska EA, (2005) How microRNAs control cell division, differentiation and death. Curr Opin Genet Dev 15: 563-568.
21. Girard M, Jacquemin E, Munnich A, Lyonnet S, Henrion-Caude A, (2008) miR-122, a paradigm for the role of microRNAs in the liver. J Hepatol 48: 648-656.
22. Sarma NJ, Yaseen NR, (2011) Amino-terminal enhancer of split (AES) interacts with the oncoprotein NUP98-HOXA9 and enhances its transforming ability. J Biol Chem 286: 38989-39001.
23. Kamal SM, Turner B, He Q, Rasenack J, Bianchi L, et al. (2006) Progression of fibrosis in hepatitis C with and without schistosomiasis: correlation with serum markers of fibrosis. Hepatology 43: 771-779.
24. Pungpapong S, Nunes DP, Krishna M, Nakhleh R, Chambers K, et al. (2008) Serum fibrosis markers can predict rapid fibrosis progression after liver transplantation for hepatitis C. Liver Transpl. 14: 1294-1302.
25. Xiao XQ, Hassanein T, Li QF, Liu W, Zheng YH, et al. (2011) YKL-40 expression in human hepatocellular carcinoma: a potential biomarker? Hepatobiliary Pancreat Dis Int 10: 605-610.
26. Sunami Y, Leithauser F, Gul S, Fiedler K, Guldiken N, et al. (2012) Hepatic activation of IKK/NF-kappaB signaling induces liver fibrosis via macrophage-mediated chronic inflammation. Hepatology.
27. Huang J, Zhang JS, Huang GC, Tang QQ, Chen C, et al. (2004) [Expression of CCAAT/enhancer-binding protein in cultured rat hepatic stellate cells and its significance]. Zhonghua Gan Zang Bing Za Zhi 12: 259-262.
28. Tao LL, Cheng YY, Ding D, Mei S, Xu JW, et al. (2012) C/EBP-alpha ameliorates CCl(4)-induced liver fibrosis in mice through promoting apoptosis of hepatic stellate cells with little apoptotic effect on hepatocytes in vitro and in vivo. Apoptosis.
29. Tseng HH, Hwang YH, Yeh KT, Chang JG, Chen YL, et al. (2009) Reduced expression of C/EBP alpha protein in hepatocellular carcinoma is associated with advanced tumor stage and shortened patient survival. J Cancer Res Clin Oncol 135: 241-247.
30. Iwai A, Takegami T, Shiozaki T, Miyazaki T, (2011) Hepatitis C virus NS3 protein can activate the Notch-signaling pathway through binding to a transcription factor, SRCAP. PLoS One 6: e20718.
31. Saad S, Stanners SR, Yong R, Tang O, Pollock CA, (2010) Notch mediated epithelial to mesenchymal transformation is associated with increased expression of the Snail transcription factor. Int J Biochem Cell Biol 42: 1115-1122.
32. Matsuno Y, Coelho AL, Jarai G, Westwick J, Hogaboam CM, (2012) Notch signaling mediates TGF-beta1-induced epithelial-mesenchymal transition through the induction of Snai1. Int J Biochem Cell Biol 44: 776-789.
33. Bielesz B, Sirin Y, Si H, Niranjan T, Gruenwald A, et al. (2010) Epithelial Notch signaling regulates interstitial fibrosis development in the kidneys of mice and humans. J Clin Invest 120: 4040-4054.
34. Lim SO, Park YM, Kim HS, Quan X, Yoo JE, et al. (2011) Notch1 differentially regulates oncogenesis by wildtype p53 overexpression and p53 mutation in grade III hepatocellular carcinoma. Hepatology 53: 1352-1362.
35. Wurmbach E, Chen YB, Khitrov G, Zhang W, Roayaie S, et al. (2007) Genome-wide molecular profiles of HCV-induced dysplasia and hepatocellular carcinoma. Hepatology 45: 938-947.
36. Lobry C, Oh P, Aifantis I, (2011) Oncogenic and tumor suppressor functions of Notch in cancer: it's NOTCH what you think. J Exp Med 208: 1931-1935.
37. Liu Y, Lou G, Wu W, Zheng M, Shi Y, et al. (2011) Involvement of the NF-kappaB pathway in multidrug resistance induced by HBx in a hepatoma cell line. J Viral Hepat 18: e439-446.
38. McCoy CE, (2012) The role of miRNAs in cytokine signaling. Front Biosci 17: 2161-2171.
39. Marquez RT, Bandyopadhyay S, Wendlandt EB, Keck K, Hoffer BA, et al. (2010) Correlation between microRNA expression levels and clinical parameters associated with chronic hepatitis C viral infection in humans. Lab Invest 90: 1727-1736.
40. Bihrer V, Waidmann O, Friedrich-Rust M, Forestier N, Susser S, et al. (2011) Serum microRNA-21 as marker for necroinflammation in hepatitis C patients with and without hepatocellular carcinoma. PLoS One 6: e26971.
41. Liu G, Friggeri A, Yang Y, Milosevic J, Ding Q, et al. (2010) miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis. J Exp Med 207: 1589-1597.
42. Farid WR, Pan Q, van der Meer AJ, de Ruiter PE, Ramakrishnaiah V, et al. (2011) Hepatocyte-derived micrornas as serum biomarker of hepatic injury and rejection after liver transplantation. Liver Transpl.
43. Basha HI, Subramanian V, Seetharam A, Nath DS, Ramachandran S, et al. (2011) Characterization of HCV-specific CD4+Th17 immunity in recurrent hepatitis C-induced liver allograft fibrosis. Am J Transplant 11: 775-785.
44. Cermelli S, Ruggieri A, Marrero JA, Ioannou GN, Beretta L, (2011) Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease. PLoS One 6: e23937.
45. Noonan EJ, Place RF, Pookot D, Basak S, Whitson JM, et al. (2009) miR-449a targets HDAC-1 and induces growth arrest in prostate cancer. Oncogene 28: 1714-1724.
46. Noonan EJ, Place RF, Basak S, Pookot D, Li LC, (2010) miR-449a causes Rb-dependent cell cycle arrest and senescence in prostate cancer cells. Oncotarget 1: 349-358.
47. Lize M, Pilarski S, Dobbelstein M, (2010) E2F1-inducible microRNA 449a/b suppresses cell proliferation and promotes apoptosis. Cell Death Differ 17: 452-458.
48. Du R, Sun W, Xia L, Zhao A, Yu Y, et al. (2012) Hypoxia-induced down-regulation of microRNA-34a promotes EMT by targeting the Notch signaling pathway in tubular epithelial cells. PLoS One 7: e30771.